Neuropathix, Inc.
NPTX · OTC
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $3,140 | $3,957 | $6,134 | $10,909 |
| - Cash | $102 | $16 | $6 | $51 |
| + Debt | $2,110 | $1,909 | $1,867 | $1,719 |
| Enterprise Value | $5,147 | $5,850 | $7,996 | $12,578 |
| Revenue | $208 | $151 | $0 | $0 |
| % Growth | 37.3% | – | – | – |
| Gross Profit | $208 | $151 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | $591 | -$607 | -$480 | -$525 |
| % Margin | 284% | -400.7% | – | – |
| Net Income | -$1,900 | -$757 | -$721 | -$751 |
| % Margin | -913.6% | -499.6% | – | – |
| EPS Diluted | -0.021 | -0.009 | -0.008 | -0.009 |
| % Growth | -139.5% | -7.5% | 5.9% | – |
| Operating Cash Flow | -$114 | -$31 | -$143 | -$270 |
| Capital Expenditures | $0 | $39 | $0 | -$7 |
| Free Cash Flow | -$114 | $8 | -$143 | -$276 |